Sanofi推出「一承诺」, 通过抗体检测推广早期糖尿病筛查。 Sanofi launches "The 1 Pledge" to promote early type one diabetes screening through antibody tests.

一类糖尿病(T1D)的早期筛查对于在出现严重并发症前发现该疾病至关重要。 Early screening for type one diabetes (T1D) is essential for detecting the disease before severe complications arise. 赛诺菲推出"The 1 Pledge"以鼓励对四个小岛自身抗体进行检测,这些抗体可以预测T1D的发展,从而降低诊断时糖尿病酸性酸症的风险. Sanofi launched "The 1 Pledge" to encourage testing for four islet autoantibodies, which can predict T1D development, reducing the risk of diabetic ketoacidosis at diagnosis. 早期筛查对儿童和成人都至关重要,因为T1D可在任何年龄发展。 Early screening is vital for both children and adults, as T1D can develop at any age. 家庭成员发展T1D的风险高出15倍,应考虑进行筛查,特别是如果家庭成员具备自动免疫条件或出现血糖症状。 Family members have a 15 times higher risk of developing T1D and should consider screening, especially if they have autoimmune conditions or exhibit glycemic symptoms.